Using an ERAS protocol for patients undergoing elective craniotomy
A Greek-designed Enhanced Recovery After Surgery (ERAS) Protocol in Elective Cranial Neurosurgical Procedures: An Observational Study
This study tests a new recovery plan for patients having brain surgery to see if it helps them heal faster and have fewer problems afterward.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Thessaly Academic / other |
| Locations | 1 site (Larissa) |
| Trial ID | NCT05962684 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of a contemporary Enhanced Recovery After Surgery (ERAS) protocol specifically designed for elective cranial neurosurgical cases at a tertiary hospital. The researchers aim to implement this protocol to assess its impact on postoperative outcomes, including length of hospital stay, complication rates, and overall clinical status of patients. By integrating the latest literature, the study seeks to provide a comprehensive approach to perioperative management in neurosurgery.
Who should consider this trial
Good fit: Ideal candidates are patients who are medically suitable for elective craniotomy and classified as ASA-PS I-III.
Not a fit: Patients with traumatic lesions, those requiring emergency surgery, or those with severe comorbidities may not benefit from this study.
Why it matters
Potential benefit: If successful, this protocol could lead to faster recovery times and fewer complications for patients undergoing elective craniotomy.
How similar studies have performed: Other studies have shown success with ERAS protocols in various surgical fields, suggesting potential for positive outcomes in this context as well.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Medically suitable for elective craniotomy * ASA-PS I-III Exclusion Criteria: * traumatic lesions * pathology requiring emergent surgery * preoperative loss of consciousness * severe co-morbidities that may affect postoperative recovery (e.g. paralysis, autoimmune diseases, myocardial or severe infarction, heart, liver or lung malfunction, severe mental illness etc.) * recurrent tumor
Where this trial is running
Larissa
- University of Thessaly — Larissa, Greece (Recruiting)
Study contacts
- Study coordinator: Eleni Arnaoutoglou, MD, PhD
- Email: earnaout@gmail.com
- Phone: +306974301352
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.